ArticleArtery research2026
Cohort Profile: The Youth Vascular Consortium.
Article in Artery research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cardiovascular disease remains the leading cause of mortality worldwide, yet its origins lie in early life. Cardiovascular risk factors track from childhood into adulthood, and vascular abnormalities detected in youth predict future cardiovascular outcomes. Despite compelling evidence, vascular assessment in youth has been impeded by a lack of reference values, standardised measurement protocols, and consensus on distinguishing physiological from pathological vascular ageing. The Youth Vascular Consortium (YVC) was established in 2020 to address these gaps through international collaboration between leading experts in the field. Results: The YVC comprises 33 research centers from 27 countries across five continents, including 29,704 participants aged 2 to 40 years. All centers assessed at least one validated vascular measure including pulse wave velocity, central blood pressure, augmentation index, intima-media thickness, carotid distensibility, or flow-mediated dilatation. The YVC has generated major outputs advancing vascular health assessment in youth, including international expert consensus on standardised definitions of early vascular ageing from birth through young adulthood and evidence-based recommendations for vascular assessment protocols. In addition, device-specific reference values for pulse wave velocity were established with age and sex specific percentile curves, enabling identification of youth with elevated arterial stiffness. Conclusions: The YVC provides an international platform for investigating vascular health from early life. Harmonising diverse datasets and establishing evidence-based standards, the Consortium aims to improve the vascular health of children and young people, thereby enabling early identification and targeted prevention strategies when vascular trajectories remain modifiable, ultimately reducing the global cardiovascular disease burden across the lifespan.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.